TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Attractiveness Analysis
1.1.1. Pharmaceutical Warehousing Market, by Service Type
1.1.2. Pharmaceutical Warehousing Market, by Mode
1.1.3. Pharmaceutical Warehousing Market, by End User
1.1.4. Pharmaceutical Warehousing Market, by Region.
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.3. Market Structure
2.4. Key Buying Criteria
2.5. Macro Factor Analysis
3. RESEARCH METHODOLOGY
3.1. Research Process
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
3.5. Forecast Model
3.6. List of Assumptions
4. MARKET DYNAMICS
4.1. Introduction
4.2. Drivers
4.2.1. Growth of the pharmaceutical industry
4.2.2. Increasing demand for temperature-controlled storage
4.3. Restraints
4.3.1. Strict regulations and quality standards
4.4. Opportunities
4.4.1. Growing popularity of e-commerce
4.5. Covid 19 Impact Analysis
4.5.1. Impact on Overall Pharmaceutical Warehousing Industry
4.5.1.1. Economic Impact
4.5.2. Impact on Pharmaceutical Warehousing Market
4.5.3. Impact on Supply Chain
4.5.3.1. Price Variation of Key Raw End-Users
4.5.3.2. Production Shutdown
4.5.3.3. Cash Flow Constraints
4.5.3.4. Impact on Import/Export
4.5.4. Impact on Market Demand
4.5.4.1. Impact due to restrictions/lockdown
4.5.4.2. Consumer Sentiments
4.5.5. Impact on Pricing
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis/Supply Chain Analysis
5.2. Porter’s Five Forces Model
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
6. PHARMACEUTICAL WAREHOUSING MARKET ESTIMATES & FORECAST, BY SERVICE TYPE
6.1. Introduction
6.2. Storage
6.3. Distribution
6.4. Inventory Management
6.5. Packaging
6.6. Others
7. PHARMACEUTICAL WAREHOUSING MARKET ESTIMATES & FORECAST, BY MODE
7.1. Introduction
7.2. Cold Chain Warehouse
7.3. Non-cold Chain Warehouse
8. PHARMACEUTICAL WAREHOUSING MARKET ESTIMATES & FORECAST, BY END USER
8.1. Introduction
8.2. Pharmaceutical Companies
8.3. Hospitals & Clinics
8.4. Research Institutes & Government Agencies
8.5. Others
9. PHARMACEUTICAL WAREHOUSING MARKET ESTIMATES & FORECAST, BY REGION
9.1. Introduction
9.2. North America
9.2.1. North America Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.2.2. North America Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.2.3. North America Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.2.4. US
9.2.4.1. US Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.2.4.2. US Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.2.4.3. US Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.2.5. Canada
9.2.5.1. Canada Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.2.5.2. Canada Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.2.5.3. Canada Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.2.6. Mexico
9.2.6.1. Mexico Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.2.6.2. Mexico Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.2.6.3. Mexico Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.3. Europe
9.3.1. Europe Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.3.2. Europe Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.3.3. Europe Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.3.4. Germany
9.3.4.1. Germany Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.3.4.2. Germany Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.3.4.3. Germany Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.3.5. France
9.3.5.1. France Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.3.5.2. France Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.3.5.3. France Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.3.6. UK
9.3.6.1. UK Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.3.6.2. UK Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.3.6.3. UK Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.3.7. Italy
9.3.7.1. Italy Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.3.7.2. Italy Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.3.7.3. Italy Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.3.8. Spain
9.3.8.1. Spain Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.3.8.2. Spain Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.3.8.3. Spain Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.3.9. Rest of Europe
9.3.9.1. Rest of Europe Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.3.9.2. Rest of Europe Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.3.9.3. Rest of Europe Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.4. Asia-Pacific
9.4.1. Asia-Pacific Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.4.2. Asia-Pacific Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.4.3. Asia-Pacific Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.4.4. China
9.4.4.1. China Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.4.4.2. China Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.4.4.3. China Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.4.5. India
9.4.5.1. India Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.4.5.2. India Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.4.5.3. India Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.4.6. Japan
9.4.6.1. Japan Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.4.6.2. Japan Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.4.6.3. Japan Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.4.7. South Korea
9.4.7.1. South Korea Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.4.7.2. South Korea Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.4.7.3. South Korea Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.4.8. Australia
9.4.8.1. Australia Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.4.8.2. Australia Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.4.8.3. Australia Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.4.9. Rest of Asia-Pacific
9.4.9.1. Rest of Asia-Pacific Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.4.9.2. Rest of Asia-Pacificl Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.4.9.3. Rest of Asia-Pacific Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.5. Middle East and Africa
9.5.1. Middle East and Africa Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.5.2. Middle East and Africa Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.5.3. Middle East and Africa Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.5.4. Saudi Arabia
9.5.4.1. Saudi Arabia Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.5.4.2. Saudi Arabia Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.5.4.3. Saudi Arabia Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.5.5. South Africa
9.5.5.1. South Africa Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.5.5.2. South Africa Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.5.5.3. South Africa Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.5.6. UAE
9.5.6.1. UAE Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.5.6.2. UAE Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.5.6.3. UAE Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.5.7. Rest of MEA
9.5.7.1. Rest of MEA Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.5.7.2. Rest of MEA Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.5.7.3. Rest of MEA Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.6. South America
9.6.1. South America Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.6.2. South America Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.6.3. South America Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.6.4. Brazil
9.6.4.1. Brazil Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.6.4.2. Brazil Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.6.4.3. Brazil Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.6.5. Argentina
9.6.5.1. Argentina Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.6.5.2. Argentina Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.6.5.3. Argentina Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
9.6.6. Rest of South America
9.6.6.1. Rest of South America Pharmaceutical Warehousing by Service Type (USD Billion, 2018 -2032)
9.6.6.2. Rest of South America Pharmaceutical Warehousing by Mode (USD Billion, 2018 -2032)
9.6.6.3. Rest of South America Pharmaceutical Warehousing by End User (USD Billion, 2018 -2032)
10. COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Key Players Market Share Analysis, 2022 (%)
10.3. Competitive Benchmarking
10.4. Competitor Dashboard
10.5. Major Growth Strategy in the Market
10.6. Key Developments & Growth Strategies
10.6.1. New Product Development
10.6.2. Mergers & Acquisitions
10.6.3. Contracts & Agreements
10.6.4. Expansions & Investments
11. COMPANY PROFILES
11.1. DB Schenker
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Thermo Fisher Scientific, Inc
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. UPS
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. SGA S.A.
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Cargo-Partner
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. FedEx
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. CEVA Logistics
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. DHL
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Agility
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Kuehne + Nagel
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
LIST OF TABLES
Table 1: Pharmaceutical Warehousing Market, By Region, 2018 -2032
Table 2: North America: Pharmaceutical Warehousing Market, By Mode, 2018 -2032
Table 3: North America: Pharmaceutical Warehousing Market, By End User, 2018 -2032
Table 4: North America: Pharmaceutical Warehousing Market, By Service Type, 2018 -2032
Table 5: Europe: Pharmaceutical Warehousing Market, By Mode, 2018 -2032
Table 6: Europe: Pharmaceutical Warehousing Market, By End User, 2018 -2032
Table 7: Europe: Pharmaceutical Warehousing Market, By Service Type, 2018 -2032
Table 8: Asia-Pacific: Pharmaceutical Warehousing Market, By Mode, 2018 -2032
Table 9: Asia-Pacific: Pharmaceutical Warehousing Market, By End User, 2018 -2032
Table 10: Asia-Pacific: Pharmaceutical Warehousing Market, By Service Type, 2018 -2032
Table 11: Middle East & Africa: Pharmaceutical Warehousing Market, By Mode, 2018 -2032
Table 12: Middle East & Africa: Pharmaceutical Warehousing Market, By End User, 2018 -2032
Table 13: Middle East & Africa: Pharmaceutical Warehousing Market, By Service Type, 2018 -2032
Table 14: South America: Pharmaceutical Warehousing Market, By Mode, 2018 -2032
Table 15: South America: Pharmaceutical Warehousing Market, By End User, 2018 -2032
Table 16: South America: Pharmaceutical Warehousing Market, By Service Type, 2018 -2032
List Of Figures
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: PHARMACEUTICAL WAREHOUSING MARKET
FIGURE 3 PHARMACEUTICAL WAREHOUSING MARKET ANALYSIS, BY SERVICE TYPE
FIGURE 4 PHARMACEUTICAL WAREHOUSING MARKET ANALYSIS, BY MODE
FIGURE 5 PHARMACEUTICAL WAREHOUSING MARKET ANALYSIS, BY END USER
FIGURE 6 PHARMACEUTICAL WAREHOUSING MARKET ANALYSIS, BY REGION
FIGURE 7 PHARMACEUTICAL WAREHOUSING MARKET: STRUCTURE
FIGURE 8 RESEARCH PROCESS
FIGURE 9 TOP-DOWN AND BOTTOM-UP APPROACHES
FIGURE 10 MARKET DYNAMICS: PHARMACEUTICAL WAREHOUSING MARKET
FIGURE 11 DRIVERS: IMPACT ANALYSIS
FIGURE 12 RESTRAINT: IMPACT ANALYSIS
FIGURE 13 SUPPLY CHAIN ANALYSIS: PHARMACEUTICAL WAREHOUSING MARKET
FIGURE 14 PORTER'S FIVE FORCES ANALYSIS: PHARMACEUTICAL WAREHOUSING MARKET
FIGURE 15 PHARMACEUTICAL WAREHOUSING MARKET, BY SERVICE TYPE, 2022 (% SHARE)
FIGURE 16 PHARMACEUTICAL WAREHOUSING MARKET, BY MODE, 2022 (% SHARE)
FIGURE 17 PHARMACEUTICAL WAREHOUSING MARKET, BY END USER, 2022 (% SHARE)
FIGURE 18 PHARMACEUTICAL WAREHOUSING MARKET SHARE, BY REGION, 2022 (% SHARE)
FIGURE 19 NORTH AMERICA: PHARMACEUTICAL WAREHOUSING MARKET SHARE, BY COUNTRY, 2022 (% SHARE)
FIGURE 20 EUROPE: PHARMACEUTICAL WAREHOUSING MARKET SHARE, BY COUNTRY, 2022 (% SHARE)
FIGURE 21 ASIA PACIFIC: PHARMACEUTICAL WAREHOUSING MARKET SHARE, BY COUNTRY, 2022 (% SHARE)
FIGURE 22 MIDDLE EAST & AFRICA: PHARMACEUTICAL WAREHOUSING MARKET SHARE, BY COUNTRY, 2022 (% SHARE)
FIGURE 23 SOUTH AMERICA: PHARMACEUTICAL WAREHOUSING MARKET SHARE, BY COUNTRY, 2022 (% SHARE)
FIGURE 24 MAJOR MANUFACTURERS MARKET SHARE ANALYSIS, 2022
FIGURE 25 CONTRACTS & AGREEMENTS: THE MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE PHARMACEUTICAL WAREHOUSING MARKET
FIGURE 26 DB SCHENKER: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 DB SCHENKER: SWOT ANALYSIS
FIGURE 28 THERMO FISHER SCIENTIFIC, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 THERMO FISHER SCIENTIFIC, INC: SWOT ANALYSIS
FIGURE 30 UPS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 UPS: SWOT ANALYSIS
FIGURE 32 SGA S.A.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 SGA S.A.: SWOT ANALYSIS
FIGURE 34 CARGO-PARTNER: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 CARGO-PARTNER: SWOT ANALYSIS
FIGURE 36 FEDEX: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 FEDEX: SWOT ANALYSIS
FIGURE 38 CEVA LOGISTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 CEVA LOGISTICS: SWOT ANALYSIS
FIGURE 40 DHL: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 DHL: SWOT ANALYSIS
FIGURE 42 AGILITY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 43 AGILITY: SWOT ANALYSIS
FIGURE 44 KUEHNE + NAGEL: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 45 KUEHNE + NAGEL: SWOT ANALYSIS